Sana Biotechnology, Inc. Financials

Market Capitalization $719.5 Million as of July 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-2.32
Forward PE	-1.68
Price to Sales TTM	$
Price to Book MRQ	$1.26
Enterprise to Revenue
Enterprise to EBITDA	-0.93

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	0.00%
Operating Margin	0.00%
Return on Assets TTM	-31.15%
Return on Equity TTM	-92.90%

Income Statement

Revenue TTM	$0
Revenue per Share TTM	$0.00
Quarterly Revenue Growth	%
Gross Profit TTM	$0
EBITDA	$-273,800,000
Net Income to Common TTM	$-305,807,008
Diluted EPS TTM	$-1.40
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	$199,007,008
Total Cash per Share MRQ	$0.89
Total Debt MRQ	$
Total Debt to Equity MRQ	32.85
Current Ratio MRQ	4.47
Book Value per Share MRQ	$1.31

Cash Flow

Operating Cash Flow TTM	$-227,951,008
Levered Free Cash Flow TTM	$-187,322,256

SANA Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	223,268,992
Float Shares	130,913,713
Avg 10 Volume	2,541,291
Avg 30 Volume	None
Shares Short	35,152,956
Short Ratio	20.07
Short % of Shares	32.55%
% Held by Insiders	8.63%
% Held by Institutions	92.46%

Stock Price Summary

Beta	1.44
Fifty Two Week Low	$1.52
Fifty Two Week High	$12.00
Fifty Two Week Change	-76.92%
Day 50 MA	$3.00
Day 200 MA	$5.83

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date